Cannara Biotech Reports Fourth Quarter and 2023 Fiscal Year Results: Record Growth and Profitability Continues

Record Q4 and year end net revenues of $18.3 million and $57.6 million, representing a 53% and 60% increase compared to the same periods of 2022 Sequentially,...

Related Keywords

Montreal ,Quebec ,Canada ,United Kingdom ,Valleyfield ,Fife ,British ,Canadian ,Zohar Krivorot ,Venture Exchange ,Regulation Services Provider ,Cannara Biotech Inc ,Chief Executive ,British Columbia ,Weed Crawler ,Headset Data ,Fourth Quarter ,Valleyfield Facility ,Farnham Facility ,Consolidated Financial Statements ,Statement Regarding ,